hotspot -WSS

hotspot

author：knowledge 2025-10-01 10:58:18 - browse：77

Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT — Adobe

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Sage hopes for a blockbuster in antidepressant now before FDA

leisure time

WSS

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Ascension's ugly legal battle over care for poor patients in Texas

Physician groups backed by private equity giant lobby on mergers

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

leisure time

hotspot

explore

Activists slam private health insurers over coverage restrictions

‘Oppenheimer’ and the risks of AI in health care

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Arena BioWorks launches in Cambridge to speed drug discovery

How to save PrEP access — and even expand it

Gene therapy denied for Afghan refugee whose father aided U.S.

Bright Health sells Medicare Advantage business to Molina

FDA early review: GLP

Affirmative action in medical school literally saved lives

Amazon expands telehealth clinic nationwide

leisure time

Study suggests new cause of Down syndrome: cells linked to aging

JPM pitch from hospitals? Revenue streams outside of patient care

NIH launches clinical trials and new research office for long Covid

What to expect as Trump is arraigned on his Jan 6. indictment

Hospital chaplains balance Covid safety with patients’ spiritual needs

Nonprofit, backed by Microsoft, to certify AI tools in health care

leisure time

leisure time

knowledge

explore